Patent No. US 11,696,902 B2
Continuation-in-part of Patent No. US 10,512,620
This disclosure provides a method of safely and rapidly initiating or escalating oral sotalol therapy by administering an intravenous dosage of sotalol followed by oral sotalol twice daily.
